AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
(From Chemical Business NewsBase - Press Release)
Swiss Medica is pleased to announce that the randomised double blind clinical trial using the O24 pain relief product on patients suffering from fibromyalgia has been completed and a final report will be issued in Jan 2005. The clinical trials, which began 1 Oct 2004, were recently concluded, according to Dr Gordon Ko, medical director of the Canadian Centre for Integrative Medicine, who conducted the study. The results are currently being analysed by the…